GENE ONLINE|News &
Opinion
Blog

Depression
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
Marijuana for Medical Use Increases the Risk of Cannabis Use Disorder
2022-03-25
History on Depression Therapy: the Past and the Psychedelic Future
2022-03-21
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
SECUADO – The Hope to Enhance Schizophrenia Patients’ Quality of Life
2019-11-14
Weekly in Asia|SEP
2019-09-27
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
Top 3 Announcements at the J.P. Morgan Healthcare Conference 2019
2019-01-13
LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!